Dimensional Fund Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Dimensional Fund Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-41,356	Closed	-$4.03M	–	3391
2015 Q1	$4.03M	Buy	41,356 +41,252	+39,665%	+$4.37M	﹤0.01%	2634
2014 Q4	$10K	Hold	104	–	–	﹤0.01%	3458
2014 Q3	$7K	Sell	104 -8,747	-99%	-$626K	﹤0.01%	3497
2014 Q2	$927K	Buy	8,851 +4,206	+91%	+$358K	﹤0.01%	3053
2014 Q1	$385K	Buy	4,645 +3,859	+491%	+$357K	﹤0.01%	3229
2013 Q4	$51K	Sell	786 -19,726	-96%	-$1.17M	﹤0.01%	3415
2013 Q3	$1.3M	Sell	20,512 -37,000	-64%	-$1.82M	﹤0.01%	2977
2013 Q2	$2.42M	Buy	+57,512	New	+$2.62M	﹤0.01%	2773

Dimensional Fund Advisors's GEVA Position: Q2 2015 in Review

Dimensional Fund Advisors sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 41,356 shares — an estimated $4.03M sold.

Dimensional Fund Advisors first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $4.03M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Dimensional Fund Advisors reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Dimensional Fund Advisors sold 41,356 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $4.03M.
Dimensional Fund Advisors first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
Dimensional Fund Advisors's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $4.03M in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Dimensional Fund Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.